Evidence map›Paper›PMID 30454748›Full record

ReviewPediatric clinics of North America2019

Long-Term Outcomes of Kidney Transplantation in Children.

Pamela D Winterberg, Rouba Garro

Abstract readReview
In one paragraph

Review in Pediatric clinics of North America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pediatric Kidney Transplantation: A Systematic Review.Children (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Article
  14. Overcoming anatomical barriers in pediatric kidney transplantation.Pediatric nephrology (Berlin, Germany) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pamela D WinterbergDivision of Pediatric Nephrology, Emory University School of Medicine, Children's Pediatric Institute, 2015 Uppergate Drive NE, 5th Floor, Atlanta, GA 30322, USA. Electronic address: pdwinte@emory.edu.
Rouba GarroDivision of Pediatric Nephrology, Emory University School of Medicine, Children's Pediatric Institute, 2015 Uppergate Drive NE, 5th Floor, Atlanta, GA 30322, USA.

Funding

Role of T cells in Uremic CardiomyopathyK08DK111998 · NIDDK · EMORY UNIVERSITY · PI WINTERBERG, PAMELA D · 2017 to 2022
$810k
NIDDK NIH HHS K08 DK111998
6 · The paper itself

Abstract

Kidney transplantation is the preferred treatment for end-stage renal disease (ESRD) in children and confers improved survival, skeletal growth, heath-related quality of life, and neuropsychological development compared with dialysis. Kidney transplantation in children with ESRD results in 10-year patient survival exceeding 90%. Therefore, the long-term management of these patients is focused on maintaining quality of life and minimizing long-term side effects of immunosuppression. Optimal management of pediatric kidney transplant recipients includes preventing rejection and infection, identifying and reducing the cardiovascular and metabolic effects of long-term immunosuppressive therapy, supporting normal growth and development, and managing a smooth transition into adulthood.

Indexed as

Kidney TransplantationQuality of LifeAdolescentChildGraft RejectionHumansImmunosuppressive AgentsKidney Failure, ChronicYoung AdultImmunosuppressive AgentsKidney transplantationOutcomesPediatric

Identifiers

PMID30454748
PMCPMC6251502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.